Days after grabbing headlines with its COVID-19 'vaccine for the world,' AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting speedy U.S. and EU regulatory approval.
Business & Financial News, U.S & International Breaking News
Asian shares grind lower amid vaccine doubts, economic concern
Asian shares fell slightly on Friday, pulling back from a record high hit earlier this week, amid renewed doubts about a highly-anticipated coronavirus vaccine and concern about the economic impact from the pandemic.
Disney increases planned layoffs to 32,000 as virus hits park attendance
Walt Disney Co said on Wednesday it would lay off about 32,000 workers, primarily at its theme parks, an increase from the 28,000 it announced in September, as the company struggles with limited customers due to the coronavirus pandemic.
Britain to curb Google and Facebook with tougher competition rules
Britain will impose a new competition regime next year to prevent Google and Facebook using their dominance to push out smaller firms and disadvantage consumers.
Hong Kong activist tells German paper he's doing well in prison isolation
Hong Kong pro-democracy activist Joshua Wong told a German newspaper he was doing well despite being held in solitary confinement and having trouble sleeping because of bright lights after he was remanded in custody this week.
Turkey does not expect U.S. sanctions over Russian S-400s under Biden
Turkey does not expect ties with the United States to be strained under President-elect Joe Biden and does not anticipate sanctions over its purchase of Russia S-400 defence systems, a senior official in President Tayyip Erdogan's AK Party said.
Ethiopia to launch 'final phase' of offensive in Tigray region, says PM
The Ethiopian military will begin the "final phase" of an offensive in the northern Tigray region, Prime Minister Abiy Ahmed said on Thursday, after an ultimatum expired for Tigrayan forces to surrender.
Have a news tip?
Reuters provides several ways to securely and confidentially share information and materials with our journalists.LEARN MORE ››